Popular weight-loss drugs such as Ozempic and Wegovy, hailed as miracle solutions for obesity, may come with a hidden cost—significant muscle loss. A new study has raised alarms among health professionals, suggesting that these medications, while effective for shedding pounds, could also weaken the body's lean tissue.
The Muscle Dilemma
Researchers have found that drugs containing semaglutide, the active ingredient in Ozempic, not only reduce fat but also lead to a notable decrease in muscle mass. This side effect is particularly concerning for older adults, who are already at risk of age-related muscle deterioration.
Expert Warnings
Dr. Julio Rosenstock, a leading diabetes specialist, emphasised that while these drugs are transformative for weight management, the loss of muscle could have serious long-term consequences. "Patients need to be aware that rapid weight loss isn't always healthy," he cautioned.
Balancing Benefits and Risks
Despite the concerns, semaglutide-based drugs remain a breakthrough for many struggling with obesity and type 2 diabetes. However, experts now recommend combining these treatments with strength training and protein-rich diets to mitigate muscle loss.
What's the Alternative?
For those wary of pharmaceutical solutions, nutritionists suggest focusing on sustainable lifestyle changes. "There's no shortcut to health," says Dr. Sarah Berry, a nutrition scientist. "A balanced diet and regular exercise are still the gold standard."
As the debate continues, one thing is clear: the conversation around weight-loss drugs is far from over.
